Tower Research Capital LLC (Trc) Cidara Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.64 - $0.92 $2,158 - $3,103
-3,373 Reduced 27.16%
9,048 $8,000
Q4 2023

Feb 13, 2024
BUY
$0.68 - $0.97 $6,558 - $9,355
9,645 Added 347.44%
12,421 $9,000
Q3 2023

Nov 14, 2023
SELL
$0.77 - $1.16 $6,911 - $10,412
-8,976 Reduced 76.38%
2,776 $2,000
Q2 2023

Aug 14, 2023
BUY
$1.01 - $1.42 $11,667 - $16,403
11,552 Added 5776.0%
11,752 $13,000
Q1 2023

May 09, 2023
SELL
$0.75 - $1.98 $15,927 - $42,047
-21,236 Reduced 99.07%
200 $0
Q4 2022

Feb 10, 2023
BUY
$0.48 - $13.08 $4,134 - $112,658
8,613 Added 67.17%
21,436 $16,000
Q3 2022

Nov 10, 2022
SELL
$0.45 - $13.0 $4,231 - $122,252
-9,404 Reduced 42.31%
12,823 $8,000
Q2 2022

Aug 15, 2022
BUY
$0.43 - $0.91 $5,859 - $12,399
13,626 Added 158.42%
22,227 $11,000
Q1 2022

May 12, 2022
SELL
$0.67 - $1.39 $2,213 - $4,592
-3,304 Reduced 27.75%
8,601 $7,000
Q4 2021

Feb 14, 2022
BUY
$1.18 - $2.18 $8,288 - $15,312
7,024 Added 143.9%
11,905 $15,000
Q3 2021

Nov 15, 2021
BUY
$1.48 - $2.35 $7,223 - $11,470
4,881 New
4,881 $11,000
Q2 2021

Aug 16, 2021
SELL
$1.87 - $2.7 $19,827 - $28,628
-10,603 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$2.06 - $3.01 $2,309 - $3,374
1,121 Added 11.82%
10,603 $28,000
Q4 2020

Feb 16, 2021
SELL
$1.99 - $3.25 $46,382 - $75,751
-23,308 Reduced 71.08%
9,482 $19,000
Q3 2020

Nov 16, 2020
BUY
$2.85 - $4.1 $14,916 - $21,459
5,234 Added 18.99%
32,790 $93,000
Q2 2020

Aug 13, 2020
BUY
$2.39 - $4.0 $65,858 - $110,224
27,556 New
27,556 $102,000
Q4 2019

Feb 07, 2020
SELL
$1.77 - $3.84 $1,189 - $2,580
-672 Closed
0 $0
Q3 2019

Nov 05, 2019
BUY
$1.25 - $2.35 $742 - $1,395
594 Added 761.54%
672 $1,000
Q2 2019

Aug 13, 2019
SELL
$1.49 - $2.94 $18,975 - $37,440
-12,735 Reduced 99.39%
78 $0
Q1 2019

May 14, 2019
BUY
$2.35 - $3.27 $26,980 - $37,542
11,481 Added 861.94%
12,813 $34,000
Q4 2018

Feb 14, 2019
SELL
$2.1 - $4.5 $29,370 - $62,937
-13,986 Reduced 91.3%
1,332 $3,000
Q3 2018

Nov 13, 2018
BUY
$3.7 - $5.25 $38,520 - $54,657
10,411 Added 212.17%
15,318 $68,000
Q2 2018

Aug 15, 2018
BUY
$3.75 - $6.05 $5,786 - $9,335
1,543 Added 45.87%
4,907 $26,000
Q1 2018

May 15, 2018
BUY
$4.0 - $8.15 $10,724 - $21,850
2,681 Added 392.53%
3,364 $14,000
Q4 2017

Feb 09, 2018
BUY
$6.35 - $8.75 $2,876 - $3,963
453 Added 196.96%
683 $5,000
Q3 2017

Nov 14, 2017
BUY
$5.75 - $8.1 $1,322 - $1,863
230
230 $2,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email